Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

ORM-12741

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
ORM‐12741 is a novel selective antagonist of alpha‐2C adrenoceptors. This trial evaluated the safety and efficacy of ORM‐12741 in… Expand
2017
2017
Treatment of TBI remains a major unmet medical need, with 2.5 million new cases of traumatic brain injury (TBI) each year in… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
2014
2014
OBJECTIVES Our primary purpose was to evaluate the efficacy of the high-potency α2C-adrenoceptor antagonist ORM-12741 in the… Expand
  • table 1
  • figure 1
2014
2014
Objectives. Our primary purpose was to evaluate the efficacy of the high-potency a2C-adrenoceptor antagonist ORM-12741 in the… Expand
  • table 1
  • figure 1
Review
2013
Review
2013
WCN 2013 No: 1048 Topic: 5 — Dementia Dementia diagnoses in the young are based on inadequate diagnostic evaluations — A… Expand